Search Results for 'Coronary stent'

6 results found.

Boston’s €75m bonanza for Ballybrit

image preview

New, purpose-built laboratories in Boston’s Building 2 – where construction commenced in 2023 – will provide facilities for teams to design, develop and test next-generation medical technologies across a range of cardiovascular therapies, as well as areas such as heart failure and renal denervation, where a catheter in the kidney can reduce blood pressure.

Innovative device manufactured in Ballybrit to benefit patients across Europe

The Promus PREMIER™ Stent System, a new generation coronary stent manufactured by Boston Scientific in Ballybrit, Galway, was successfully implanted for the first time worldwide at the Trinity Centre for Health Sciences at the 10th Annual Live PCI Course held at St. James Hospital this month. This is the seventh drug-eluting coronary stent developed and commercialised by Boston Scientific over the past 10 years.

Innovative device manufactured in Ballybrit to benefit patients across Europe

The Promus PREMIER™ Stent System, a new generation coronary stent manufactured by Boston Scientific in Ballybrit, Galway, was successfully implanted for the first time worldwide at the Trinity Centre for Health Sciences at the 10th Annual Live PCI Course held at St. James Hospital this month. This is the seventh drug-eluting coronary stent developed and commercialised by Boston Scientific over the past 10 years.

UHG first to use ground-breaking cardiology technology

image preview

The Cardiology Department in University Hospital Galway has become the first department in Ireland to use ground-breaking cardiology technology, which will significantly improve the detection of cholesterol build narrowings within the coronary artery.

First quarter losses for two healthcare giants despite sales increase

Two healthcare giants based in the midlands and the west have this week posted first quarter losses — despite a massive increase in sales in both companies.

Galway med firm raises €12 million to fund first product

A MEDICAL devices group based in Ballybrit has raised $17.3 million (€12.4 million) in funding to launch the company’s first product — a coronary stent designed to prevent blockages of smaller arteries feeding the heart.

 

Page generated in 0.0403 seconds.